Rafael Holdings, Inc. (RFL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rafael Holdings, Inc. (RFL) has a cash flow conversion efficiency ratio of -0.090x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.51 Million) by net assets ($83.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Rafael Holdings, Inc. (RFL) defensive interval to measure how many days the company can operate on defensive assets alone.
Rafael Holdings, Inc. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Rafael Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Rafael Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rafael Holdings, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kura Sushi Asia Co Ltd
TWO:2754
|
0.118x |
|
Viceroy Hotels Limited
NSE:VHLTD
|
0.132x |
|
New Horizon Aircraft Ltd
NASDAQ:HOVR
|
-0.482x |
|
AVATION PLC LS-01
F:9K0
|
N/A |
|
Sound Financial Bancorp Inc
NASDAQ:SFBC
|
0.018x |
|
Data International Co Ltd
TWO:5432
|
0.095x |
|
Sunfon Construction Co Ltd
TWO:5514
|
-0.056x |
|
Han Chang Pape
KO:009460
|
0.054x |
Annual Cash Flow Conversion Efficiency for Rafael Holdings, Inc. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Rafael Holdings, Inc. from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Rafael Holdings, Inc..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | $98.37 Million | $-18.92 Million | -0.192x | -112.69% |
| 2024-07-31 | $86.26 Million | $-7.80 Million | -0.090x | +19.71% |
| 2023-07-31 | $96.63 Million | $-10.89 Million | -0.113x | +58.01% |
| 2022-07-31 | $97.21 Million | $-26.08 Million | -0.268x | -135.09% |
| 2021-07-31 | $136.70 Million | $-15.60 Million | -0.114x | -219.25% |
| 2020-07-31 | $130.53 Million | $-4.67 Million | -0.036x | -42.40% |
| 2019-07-31 | $124.76 Million | $-3.13 Million | -0.025x | -59.84% |
| 2018-07-31 | $115.56 Million | $-1.81 Million | -0.016x | +39.93% |
| 2017-07-31 | $62.08 Million | $-1.62 Million | -0.026x | -1872.49% |
| 2016-07-31 | $48.81 Million | $72.00K | 0.001x | -- |
About Rafael Holdings, Inc.
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells… Read more